Phase II trial of imatinib mesylate plus hydroxyurea in the treatment of patients with malignant glioma

被引:0
作者
Reardon, D
Friedman, A
Herndon, J
Quinn, J
Rich, J
Vredenburgh, J
Badruddoja, M
Desjardins, A
Sampson, J
Gururangan, S
Dowell, J
Affronti, M
Allen, D
Jackson, S
Zeigler, K
Silverman, S
Tourt-Uhlig, S
Silverman, S
Salvado, A
Nikolova, Z
Bigner, D
Friedman, H
机构
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Novartis Pharmaceut Corp, E Hanover, NJ USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:381 / 381
页数:1
相关论文
empty
未找到相关数据